Get in Touch

NanoView Biosciences to Present at the Biotech Showcase™ Annual Conference on January 14, 2020

BOSTON, MA — January 8, 2020 — NanoView Biosciences, Inc., today announced that Jerry Williamson, Chief Executive Officer, is scheduled to present at Biotech Showcase™ 2020 taking place on January 13-15, 2020 at the Hilton San Francisco Union Square, San Francisco, CA. NanoView’s proprietary product, the ExoView™ system, enables life science researchers to better understand the biological role of exosomes. 

Details for the presentation are as follows:

Date: January 14, 2020

Time: 3:45 pm PST

Room: Hilton/Franciscan D, Ballroom Level

Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA

The ExoView platform is designed For Research Use Only. It is not for use in diagnostic procedures.

About NanoView Biosciences

NanoView Biosciences, a Boston-based, privately-held company, is focused on enabling life science researchers to better understand the biological role of exosomes and their potential use as biomarkers for improving the diagnosis, prognosis, treatment, and monitoring of disease. The company’s proprietary product, the ExoView™ platform, was designed to fully characterize exosomes and other extracellular vesicles for use in research and in the implementation of precision medicine. ExoView is a high-throughput, cost-effective analysis platform that is easy to use and does not require purification or large sample volumes to accurately analyze exosomes.

www.nanoviewbio.com

Key Takeaways
  • Presenting at Biotech Showcase January 14, at 3:45 pm PST
  • Presentation will be held in the Hilton/Franciscan D, Ballroom Level at the Hilton San Francisco Union Square Hotel
  • NanoView’s proprietary product, the ExoView™ system, enables life science researchers to better understand the biological role of exosomes.
Media Gallery
Related Bios
Jerry Williamson
CEO
View Full Bio>>
Contacts
Michelle Linn
michelle@bioscribe.com
774-696-3803
BioScribe